» Authors » Nitin Rustogi

Nitin Rustogi

Explore the profile of Nitin Rustogi including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 23
Citations 318
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Rustogi N, Talapa R, Yadav J
J Family Med Prim Care . 2024 Jul; 13(7):2772-2775. PMID: 39071006
In this case series, we report a 32-year-old male patient with myocardial infarction and 45-year-old female with portal vein thrombosis with splenic infarcts, which were the initial manifestations of polycythaemia...
2.
Odunze U, Rustogi N, Devine P, Miller L, Pereira S, Vashist S, et al.
Nucleic Acids Res . 2024 Jul; 52(16):9384-9396. PMID: 39051560
Lipid nanoparticles (LNPs) have been demonstrated to hold great promise for the clinical advancement of RNA therapeutics. Continued exploration of LNPs for application in new disease areas requires identification and...
3.
Zaki J, Lago S, Spadaro B, Rustogi N, Gangadin S, Benacek J, et al.
Schizophr Res . 2024 Feb; 266:66-74. PMID: 38377869
Schizophrenia is one of the most debilitating mental disorders, and its diagnosis and treatment present significant challenges. Several clinical trials have previously evaluated the effectiveness of simvastatin, a lipid-lowering medication,...
4.
Tomasik J, Harrison S, Rustogi N, Olmert T, Barton-Owen G, Han S, et al.
JAMA Psychiatry . 2023 Oct; 81(1):101-106. PMID: 37878349
Importance: Bipolar disorder (BD) is frequently misdiagnosed as major depressive disorder (MDD) because of overlapping symptoms and the lack of objective diagnostic tools. Objective: To identify a reproducible metabolomic biomarker...
5.
Zaki J, Lago S, Rustogi N, Gangadin S, Benacek J, van Rees G, et al.
Transl Psychiatry . 2022 Oct; 12(1):457. PMID: 36310155
A significant proportion of the personal and economic burden of schizophrenia can be attributed to the late diagnosis or misdiagnosis of the disorder. A novel, objective diagnostic approaches could facilitate...
6.
Lago S, Tomasik J, van Rees G, Rustogi N, Vazquez-Bourgon J, Papiol S, et al.
Brain Behav Immun . 2022 Apr; 103:37-49. PMID: 35381347
Despite being a major cause of disability worldwide, the pathophysiology of schizophrenia and molecular basis of treatment response heterogeneity continue to be unresolved. Recent evidence suggests that multiple aspects of...
7.
Kapustin A, Davey P, Longmire D, Matthews C, Linnane E, Rustogi N, et al.
Commun Biol . 2021 Nov; 4(1):1241. PMID: 34725463
Next generation modified antisense oligonucleotides (ASOs) are commercially approved new therapeutic modalities, yet poor productive uptake and endosomal entrapment in tumour cells limit their broad application. Here we compare intracellular...
8.
Tomasik J, Han S, Barton-Owen G, Mirea D, Martin-Key N, Rustogi N, et al.
Transl Psychiatry . 2021 Jan; 11(1):41. PMID: 33436544
The vast personal and economic burden of mood disorders is largely caused by their under- and misdiagnosis, which is associated with ineffective treatment and worsening of outcomes. Here, we aimed...
9.
Han S, Tomasik J, Rustogi N, Lago S, Barton-Owen G, Eljasz P, et al.
Brain Behav Immun . 2020 Aug; 90:184-195. PMID: 32861718
With less than half of patients with major depressive disorder (MDD) correctly diagnosed within the primary care setting, there is a clinical need to develop an objective and readily accessible...
10.
Olmert T, Cooper J, Han S, Barton-Owen G, Farrag L, Bell E, et al.
JMIR Res Protoc . 2020 Aug; 9(8):e18453. PMID: 32773373
Background: Mood disorders affect hundreds of millions of people worldwide, imposing a substantial medical and economic burden. Existing diagnostic methods for mood disorders often result in a delay until accurate...